Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Revill

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Medical Virology|November 19, 2016
Genotypic profiles of hepatitis B in African immigrants and their clinical relevanceMaria Christine Thurnheer, Rosalind Edwards, Thomas Ray Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
United European Gastroenterology Journal|June 12, 2014
Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patientsCosmas Rinaldi Adithya Lesmana, Kathy Jackson, Seng Gee Lim, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
Microbiology Spectrum|July 23, 2025
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model systemWei Zhao, Kasha Singh, Vitini Sozzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Cell Death & Disease|June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P Clark, Thao Huynh, Shringar Rao, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medical Virology|November 19, 2016
Genotypic profiles of hepatitis B in African immigrants and their clinical relevanceMaria Christine Thurnheer, Rosalind Edwards, Thomas Ray Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
United European Gastroenterology Journal|June 12, 2014
Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patientsCosmas Rinaldi Adithya Lesmana, Kathy Jackson, Seng Gee Lim, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
Microbiology Spectrum|July 23, 2025
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model systemWei Zhao, Kasha Singh, Vitini Sozzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Cell Death & Disease|June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P Clark, Thao Huynh, Shringar Rao, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 5